Is Arbutus Biopharma Corp halal to invest in?

As of July 2026, Arbutus Biopharma Corp I9DN.SG is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Arbutus Biopharma Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Arbutus Biopharma Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Arbutus Biopharma Corp?

Muslim investors may consider investing in Arbutus Biopharma Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Arbutus Biopharma Corp classified as HALAL?

Musaffa determines the Shariah status of Arbutus Biopharma Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Arbutus Biopharma Corp updated?

The Shariah compliance status of Arbutus Biopharma Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Arbutus Biopharma Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Arbutus Biopharma Corp?

You can check the latest Shariah compliance status of Arbutus Biopharma Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Arbutus Biopharma Corp I9DN.SG

Last Updated: Jul 17, 12:00 AM·XSTU

I9DN.SG Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Arbutus Biopharma Corp is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Arbutus Biopharma Corp. Stock Analysis I9DN.SG

Germany Health Care Small Cap Report: Q1, 2026

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. The company is headquartered in Warminster, British Columbia and currently employs 19 full-time employees. The company went IPO on 2010-11-13. The firm is developing imdusiran (AB-729), its proprietary, conjugated GalNAc, subcutaneously delivered RNAi therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). Its HBV product pipeline includes Imdusiran and AB-101. Its pipeline includes two product candidates that target various steps in the HBV viral lifecycle and consists of various programs: RNAi therapeutic (imdusiran, AB-729) and Oral PD-L1 Inhibitor (AB-101). RNAi therapeutics utilize a natural pathway within cells to silence genes by eliminating the disease-causing proteins that they code for. PD-L1 inhibitors complement its pipeline of agents and could potentially be a part of a combination therapy for the treatment of HBV by reawakening the immune system.

Key Statistics of Arbutus Biopharma Corp (I9DN.SG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€4.07€4.20

Today's Open

€4.01

Volume

150.00

P/E Ratio (TTM)

Financial Metrics & Statements of Arbutus Biopharma Corp (I9DN.SG)

Super Investors Invested in Arbutus Biopharma Corp (I9DN.SG)

FAQ's for Arbutus Biopharma Corp (I9DN.SG)

As of July 2026, Arbutus Biopharma Corp I9DN.SG is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Arbutus Biopharma Corp using these criteria to determine its compliance status.
Muslim investors may consider investing in Arbutus Biopharma Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Arbutus Biopharma Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Arbutus Biopharma Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Arbutus Biopharma Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.